XTX Topco’s Quoin Pharmaceuticals QNRX Stock Holding History

XTX Topco’s Portfolio QNRX Stock Details QNRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-887	Closed	-$20.2K	–	2969
2024 Q4	$20.2K	Buy	+887	New	+$20.4K	﹤0.01%	2041

Other funds holding QNRX

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AWM

Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

XTX Topco's QNRX Position: Q1 2025 in Review

XTX Topco sold out of Quoin Pharmaceuticals (QNRX) in Q1 2025, closing a stake of 887 shares — an estimated $20.2K sold.

XTX Topco first reported a position in QNRX in Q4 2024 and held it in 1 quarter. The position peaked at $20.2K in Q4 2024. 9 funds tracked by Wall St. Rank hold QNRX as of Q1 2025.

XTX Topco reported no remaining Quoin Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
XTX Topco sold 887 Quoin Pharmaceuticals shares in Q1 2025, an estimated $20.2K.
XTX Topco first reported a position in Quoin Pharmaceuticals in Q4 2024 and held it in 1 quarter.
XTX Topco's Quoin Pharmaceuticals position peaked at $20.2K in Q4 2024.
9 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.